Moreover, α-PD-1 treatment did not further improve OT-1 T cell tumor-killing effects mediated by shUSP24, suggesting that enhanced T cell cytotoxicity mediated by USP24 inhibition is directly attributed to the decreased PD-1 levels (fig. The gene discussed is USP24; the disease is neoplasm.